Two Sigma Advisers’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-58,000
| Closed | -$1.04M | – | 2607 |
|
|
2025
Q1 | $1.04M | Buy |
+58,000
| New | +$1.03M | ﹤0.01% | 1453 |
|
|
2024
Q4 | – | Sell |
-147,900
| Closed | -$1.7M | – | 2579 |
|
|
2024
Q3 | $1.7M | Sell |
147,900
-39,700
| -21% | -$456K | ﹤0.01% | 1154 |
|
|
2024
Q2 | $2.12M | Buy |
187,600
+38,900
| +26% | +$518K | ﹤0.01% | 1158 |
|
|
2024
Q1 | $2.13M | Buy |
148,700
+88,800
| +148% | +$1.26M | ﹤0.01% | 1190 |
|
|
2023
Q4 | $821K | Buy |
59,900
+5,500
| +10% | +$57.9K | ﹤0.01% | 1723 |
|
|
2023
Q3 | $442K | Buy |
54,400
+35,400
| +186% | +$289K | ﹤0.01% | 1834 |
|
|
2023
Q2 | $144K | Buy |
+19,000
| New | +$145K | ﹤0.01% | 2157 |
|
|
2023
Q1 | – | Sell |
-34,600
| Closed | -$393K | – | 2781 |
|
|
2022
Q4 | $393K | Sell |
34,600
-18,100
| -34% | -$197K | ﹤0.01% | 1971 |
|
|
2022
Q3 | $460K | Buy |
+52,700
| New | +$547K | ﹤0.01% | 1879 |
|
|
2021
Q1 | – | Sell |
-31,200
| Closed | -$566K | – | 2758 |
|
|
2020
Q4 | $566K | Buy |
+31,200
| New | +$481K | ﹤0.01% | 1822 |
|
Two Sigma Advisers's PTVE Position: Q2 2025 in Review
Two Sigma Advisers sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 58,000 shares — an estimated $1.04M sold.
Two Sigma Advisers first reported a position in PTVE in Q4 2020 and held it in 10 quarters. The position peaked at $2.13M in Q1 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Two Sigma Advisers reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Two Sigma Advisers sold 58,000 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $1.04M.
- Two Sigma Advisers first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 10 quarters.
- Two Sigma Advisers's Pactiv Evergreen Inc. Common stock position peaked at $2.13M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.